D. Filopon

PsrA Is a Positive Transcriptional Regulator of the Type III Secretion System in Pseudomonas aeruginosa

L. Kuhn, B. Polack, B. Toussaint, 2006, Infection and Immunity.

Pseudomonas aeruginosa of the Type III Secretion System in PsrA Is a Positive Transcriptional Regulator

L. Kuhn, B. Polack, B. Toussaint, 2005 .

Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector.

B. Polack, B. Guery, M. Derouazi, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

A Legionella pneumophila effector impedes host gene silencing to promote virulence

C. Buchrieser, Bérangère Lombard, D. Loew, 2024, bioRxiv.

Identification of a Brucella spp. secreted effector specifically interacting with human small GTPase Rab2

J. Rual, J. Vandenhaute, J. Twizere, 2011, Cellular microbiology.

Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa

Gilles Bernot, Jean-Paul Comet, Benoit Guery, 2006, BMC Bioinformatics.

High-cell-density regulation of the Pseudomonas aeruginosa type III secretion system: implications for tryptophan catabolites.

B. Polack, M. Derouazi, H. Chaker, 2008, Microbiology.

Optimization of a Type III Secretion System-Based Pseudomonas aeruginosa Live Vector for Antigen Delivery

B. Polack, M. Derouazi, B. Toussaint, 2007, Clinical and Vaccine Immunology.

Optimization of a Type Three Secretion System-based P. aeruginosa live vector for antigen delivery

B. Polack, M. Derouazi, B. Toussaint, 2007 .